New Protocol in Unexplained Infertility

Launched by TANTA UNIVERSITY · Feb 12, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment approach called ANTIUI for women who have unexplained infertility, meaning that doctors can't find a specific reason why they are having trouble getting pregnant. The trial aims to see if this new method can help improve ovulation and increase pregnancy rates in these patients. The study is currently recruiting female participants aged between 30 and 40 years who have been trying to conceive for less than five years and have good ovarian function.

To join the trial, women must meet certain criteria: they should have unexplained infertility, normal fallopian tubes, and no previous attempts at a specific type of fertility treatment called IUI with this protocol. However, those over 35 years old, those who have been infertile for more than five years, or those with other fertility issues will not be eligible to participate. If you join this trial, you can expect to receive the new treatment and be monitored closely to see how well it works for you in achieving pregnancy.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Unexplained infertility
• • Duration less than 5 years
• • Good ovarian reserve AMH\> 1.1
• • Normal patent tubes
• • No previous trials of IUI with the same protocol
• Exclusion Criteria:
• • Age \> 35 years
• • Duration of infertility\> 5 years
• • Abnormal semen
• • Hypoplastic tubes
• • prior failed ICSI